Schering Corporation and The Government of the U.S.A, as represented by the Secretary of the

Patent application number	Title	Published
Schering Corporation and The Government of the U.S.A, as represented by the Secretary of the Patent applications
20100111950	USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.	05-06-2010